Simple Summary The high lethality of colorectal cancer (CRC) is anticipated to continue in
the following decades. Early-stage CRC is entirely treatable with surgery and adjuvant …

Background Despite rising incidence and mortality rates in Africa, cancer has been given
low priority in the research field and in healthcare services. Indeed, 57% of all new cancer …

Each year, colorectal cancers (CRCs) affect over a quarter of a million people. The risk of
develo** CRC in industrialized nations is approximately 5%. When the disease is …

Colorectal cancer is the second most deadly type of cancer (CRC). In the upcoming
decades, death and incidence rates would surely increase globally. Despite being …

Background Colorectal cancer (CRC) is the first commonest diagnosed cancer in men and
the fourth commonest in women in Ethiopia. Awareness of CRC and associated factors is …

The incidence of colorectal cancer (CRC) is gradually rising in sub-Saharan Africa. This may
be due to dietary changes associated with urbanization, which may induce tumor-promoting …

Schistosomiasis japonicum can cause different degrees of organ damage and complex
human immune pathological reactions, which often invade the intestine and liver. The …

Background CTLA4 is a candidate gene which has been implicated in the development of
colorectal cancer (CRC). Patients and Methods To determine the important role of CTLA-4 …

Colorectal carcinoma (CRC) is the second most common cancer diagnosed in Algeria. The
incidence and the mortality rate of CRC have increased so that the nation now ranks third in …

Tumour-associated macrophages (TAMs) can be divided into M1 and M2 TAMs. M2 TAMs
play an important role in tumor progression, promoting a pro-angiogenic and …